HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,000 | -47.1% | 26,052 | -50.5% | 0.00% | – |
| Q3 2017 | $17,000 | -52.8% | 52,652 | -26.8% | 0.00% | – |
| Q2 2017 | $36,000 | -50.7% | 71,952 | -46.1% | 0.00% | – |
| Q1 2017 | $73,000 | -24.7% | 133,552 | -4.6% | 0.00% | – |
| Q4 2016 | $97,000 | -51.3% | 139,952 | -11.5% | 0.00% | – |
| Q3 2016 | $199,000 | – | 158,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 15,834 | $6,000 | 0.00% |
| Virtu Financial LLC | 34,330 | $14,000 | 0.00% |
| Waldron Private Wealth LLC | 11,000 | $4,000 | 0.00% |
| VANGUARD GROUP INC | 451,169 | $178,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,080 | $0 | 0.00% |
| UBS Group AG | 1,714 | $1,000 | 0.00% |
| Well Done, LLC | 190 | $0 | 0.00% |
| Advisor Group, Inc. | 250 | $0 | 0.00% |
| Jacobi Capital Management LLC | 318 | $0 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |